Peritoneal-urinary drainage for treatment of refractory ascites: A pilot study

Journal of Vascular and Interventional Radiology

Volumn 9, Issue 6, 1998, Pages 998-1005

  Rozenblit, Grigory N ^a   Del Guercio, Louis R M ^a   Rundback, John H ^a   Poplausky, Maurice R ^a   Lebovics, Edward ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

Ascites; Paracentesis; Peritoneum, fluid

Indexed keywords

MEGLUMINE DIATRIZOATE PLUS SODIUM DIATRIZOATE; METHYLENE BLUE;

ABDOMINAL DRAINAGE; ADULT; AGED; ARTICLE; ASCITES; ASCITES FLUID; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HUMAN; INTERVENTIONAL RADIOLOGY; MALE; PARACENTESIS; PERITONEAL CATHETER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; WEIGHT REDUCTION; WOUND HEALING;

EID: 0031772499     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(98)70440-3     Document Type: Article

References (12)

1. Olafson S, Blei AT. Diagnosis and management of ascites in the age of TIPS. AJR 1995; 165:9-15.
2. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332:1192-1197.
3. Crenshaw WB, Gordon FD, McEniff NJ, et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996; 200:185-192.
4. Baker AR, Weber JS. Treatment of malignant ascites. In: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 4th ed. Philadelphia: JB Lippincott, 1993; Volume 2:2255-2261.
5. Quiroga J, Sangro B, Nuñez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995; 21:986-994.
6. Arroyo V, Gines P, Planas R, Panes J, Rodes J. Paracentesis in the management of cirrhotics with ascites. In: Epstein M, ed. The kidney in liver disease. 3rd ed. Baltimore: Williams & Wilkins, 1988; 578-592.
7. Rubinstein D, McInnes I, Dudley F. Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites. Gut 1985; 26:1070-1073.
8. Epstein M. Role of the peritoneovenous shunt in the management of ascites and the hepatorenal syndrome. In: Epstein M, ed. The kidney in liver disease. 3rd ed. Baltimore: Williams & Wilkins, 1988; 593-612.
9. Ferral H, Bjarnason H, Wegryn SA, et al. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993; 189:795-801.
10. Martinet JP, Fenyves D, Legault L, et al. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution. Dig Dis Sci 1997; 42:161-166.
11. Lebrec D, Giuily N, Hedengue A, et al. Transjugular intrahepatic portosystemic shunt: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French group of clinicians and a group of biologists. J Hepatol 1996; 25:135-144.
12. Rozenblit G, Lebovics E, Savino J, Rundback JH, Bashir S. Observation on intrarenal and intraperitoneal pressures in patients with tense ascites: feasibility of unassisted ascites drainage into the urinary tract. Minimally Invasive Therapy and Allied Technologies 1997; 6:83-86.